| abstract |
And an evaluation method capable of providing highly reliable information that can be a reference for knowing the risk of developing AD in the future. In this embodiment, α-ABA, Ala, Arg, Asn, Cit, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Orn, Phe, Pro, Ser and Thr , At least one concentration value among Trp, Tyr, Val, Cysteine, Taurine, bABA, Ethylglycine, Hypotaurine, 3-Me-His, 5-HydroxyTrp, aAiBA, and N8-Acetylspermidine is used. Evaluate the risk of onset. |